Patent · US Active

Anti-αvβ6 antibodies

US8153126B2 · kind B2 · utility

24Cited by
17References
16Claims
0Family size

Inventors

Key dates

Filing dateOct 29, 2008
Grant dateApr 10, 2012
Priority date
Expiry dateOct 29, 2028

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/205
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Monoclonal antibodies that specifically bind to □v□□. Also included are methods of using these antibodies to treat mammals having or at risk of having □v□6-mediated diseases, or to diagnose □V□6-mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.